Owner Idera Pharmaceuticals, Inc.

Convention US 28 June 2005 78660219

Various Convention priority claimed: 28 June 2005, United States of America, No. 78660219 in respect of CLASS: 01.* Convention priority claimed: 28 June 2005, United States of America, No. 78660224 in respect of CLASS: 05.* Convention priority claimed: 28 June 20

Filing Date 11 November 2005

Class 1 Reagents for the detection of polymerase chain reactions for scientific or research use; diagnostic kits containing a reagent for the detection of polymerase chain reactions for scientific or research use; chemical products, namely, synthetic oligonucleotides for use in the manufacture of pharmaceuticals for modulating the immune system

Class 5 Medical diagnostic and therapeutic preparations, namely, biologically active modulators, including, immune modulators and antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes

Class 42 Medical and scientific services namely provision of care in the field of immunology (terms considered too vague by the International Bureau (Rule 13(2)(b) of the Common Regulations); medical and scientific research in the area of oligonucleotides or chemical products; research and development of pharmaceuticals and research products for others; biological and/or chemical research namely in the field of immunology

Class 44 Medical services, namely, providing medical care in the field of immunology